Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
sidebar [01.13.2019]
sallieq [About the MPKB Project]
sidebar [02.10.2019] (current)
sallieq [Publications and presentations]
Line 11: Line 11:
 ===== Publications and presentations ===== ===== Publications and presentations =====
  
-[[https://​www.frontiersin.org/​articles/​10.3389/​fped.2018.00373/​full|Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity]] +|[[home:publications:​Proal_frontiers_in_Pediatrics_2018|Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity]] ​- //Frontiers in Pediatrics//​ 2018|  
-|[[home:​publications:​Proal_discoverymedicine_2017|Microbe-Microbe and Host-Microbe Interactions drive inflammatory processes]] - 2017 paper in //Discovery medicine// | +|[[home:​publications:​Proal_discoverymedicine_2017|Microbe-Microbe and Host-Microbe Interactions drive inflammatory processes]] - //Discovery medicine// ​2017
-|[[home:​publications:​heil_immunologic_2016|Electrosmog and immune disease]] - paper in //​Immunologic research// on modern sources of immune suppression |+|[[home:​publications:​heil_immunologic_2016|Electrosmog and immune disease]] - //​Immunologic research// ​paper on modern sources of immune suppression|
 |[[home:​publications:​proal_discoverymedicine_2014|Inflammatory disease and the human microbiome]] - paper in //Discovery medicine// on successive infection and methods for reversal of pathogen-induced genomic dysregulation | |[[home:​publications:​proal_discoverymedicine_2014|Inflammatory disease and the human microbiome]] - paper in //Discovery medicine// on successive infection and methods for reversal of pathogen-induced genomic dysregulation |
-|[[home:​publications:​lindseth_immunologic_2013|Immunostimulation in the treatment for chronic fatigue syndrome/​myalgic encephalomyelitis]] - paper in //​Immunologic research// on the role of immunostimulation in the treatment of CFS/ME | +|[[home:​publications:​lindseth_immunologic_2013|Immunostimulation in the treatment for chronic fatigue syndrome/​myalgic encephalomyelitis]] - paper  in //​Immunologic research// on the role of immunostimulation in the treatment of CFS/ME | 
-|[[home:​publications:​Proal_Current_2013|The human microbiome and autoimmunity]] - paper in //Current opinion in rheumatology// ​which reviews ​the role of chronic pathogens in "​autoimmune"​ conditions |+|[[home:​publications:​Proal_Current_2013|The human microbiome and autoimmunity]] - paper in //Current opinion in rheumatology//​ reviews role of chronic pathogens in "​autoimmune"​ conditions |
 |[[home:​publications:​proal_molecular_2011|Immunostimulation in the era of the metagenome]] - collaborative paper in //Cellular & molecular immunology// ​ | |[[home:​publications:​proal_molecular_2011|Immunostimulation in the era of the metagenome]] - collaborative paper in //Cellular & molecular immunology// ​ |
  
Line 22: Line 22:
 ==== About Marshall Protocol Recovery ==== ==== About Marshall Protocol Recovery ====
  
-Due to differences in molecular structure, each ARB is shown to have [[home:​publications:​marshall_fda_cder_2006#​tableaffinity_of_various_arbs_and_statins_for_select_nuclear_receptors|significantly different properties]] when interacting with the nuclear receptors in the immune cells. For example: where [[home:​othertreatments:​telmisartan|Telmisartan]] would quickly and completely suppress immune function, frequent dosing of Olmesartan over a prolonged period allows recovery of immune function [[home:​protocol:​olmesartan#​vitamin_d_receptor_agonist|via activation of the vitamin D receptor]].\\ Data collected since 2004 supports the hypothesis that by also diligently avoiding every form of immune suppression,​ overall health can be maintained and the body restored to natural homeostasis. ​ +Due to differences in molecular structure, each ARB is shown to have [[home:​publications:​marshall_fda_cder_2006#​tableaffinity_of_various_arbs_and_statins_for_select_nuclear_receptors|significantly different properties]] when interacting with the nuclear receptors in the immune cells. For example: where [[home:​othertreatments:​immune_suppressants:​telmisartan|Telmisartan]] would quickly and completely suppress immune function, frequent dosing of Olmesartan over a prolonged period allows recovery of immune function [[home:​protocol:​olmesartan#​vitamin_d_receptor_agonist|via activation of the vitamin D receptor]].\\ Data collected since 2004 supports the hypothesis that by also diligently avoiding every form of immune suppression,​ overall health can be maintained and the body restored to natural homeostasis. ​
- +
- +
 ==== About Autoimmunity Research Foundation ==== ==== About Autoimmunity Research Foundation ====
  
Line 34: Line 31:
 ==== About the MPKB Project ==== ==== About the MPKB Project ====
  
-The MPKB currently ​contains about 400 pages and draws from the best evidence to support its mission. ​As of May 2011, about 85% of those articles are complete with the remainder ​awaiting completion or revision.+For benefit of research, physicians, support volunteeers,​ and other persons interested, ​ this Wiki/​Knowledge Base was created and is maintained on a voluntary basis by colleagues of Prof. Marshall 
 + 
 +The MPKB contains about 400 pages and draws from the best evidence to support its mission. ​About 15% of articles are awaiting completion or revision.
   * [[home:​index#​incomplete_articles|Incomplete articles]]   * [[home:​index#​incomplete_articles|Incomplete articles]]
   * [[home:​patients:​tipsformpkb|Tips for using this resource]]   * [[home:​patients:​tipsformpkb|Tips for using this resource]]
sidebar.1547415410.txt.gz · Last modified: 01.13.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.